Name of applicant:
|
GlaxoSmithKline plc
|
|||
Name of scheme:
|
GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan
|
|||
Period of return:
|
From:
|
1 November 2020
|
To:
|
30 April 2021
|
Balance of unallotted securities under scheme(s) from previous
return:
|
0
|
|||
Plus: The amount by
which the block scheme(s) has been increased since the date of the
last return (if any increase has been applied
for):
|
300,000
|
|||
Less: Number
of securities issued/allotted under scheme(s) during
period (see LR3.5.7G):
|
264,481
|
|||
Equals: Balance
under scheme(s) not yet issued/allotted at end of
period:
|
35,519
|
Name of applicant:
|
GlaxoSmithKline plc
|
|||
Name of scheme:
|
GlaxoSmithKline plc Share Save Plan 2012
|
|||
Period of return:
|
From:
|
1 November 2020
|
To:
|
30 April 2021
|
Balance of unallotted securities under scheme(s) from previous
return:
|
1,277,629
|
|||
Plus: The amount by
which the block scheme(s) has been increased since the date of the
last return (if any increase has been applied
for):
|
360,000
|
|||
Less: Number
of securities issued/allotted under scheme(s) during
period (see LR3.5.7G):
|
1,255,163
|
|||
Equals: Balance
under scheme(s) not yet issued/allotted at end of
period:
|
382,466
|
Name of contact:
|
Victoria Whyte
|
Telephone number of contact:
|
020 8047 5000
|
|
GlaxoSmithKline plc
|
|
(Registrant)
|
|
|
Date: May
18, 2021
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GlaxoSmithKline plc
|